Back to search
FDAFDA · Food and drugs·Recall number D-1337-2022

Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.

Published July 27, 2022 · Recall initiated: June 27, 2022

Summary

FDA records drug Class I recall D-1337-2022, published July 27, 2022 and initiated June 27, 2022. Recalling firm: Loud Muscle Science; Status: Terminated; Reported quantity: 1000 10-count tins; Lot: Lot # 2022104, Exp. Date 04/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Loud Muscle Science
Distributor
The product was distributed nationwide in the USA and Canada.
UPC
661020846864
Lot
Lot # 2022104, Exp. Date 04/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864. recalled?

Yes. FDA published recall D-1337-2022 on July 27, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 661020846864.